In this issue:
- Modifiable risk factors and long-term type 2 diabetes risk after gestational diabetes
- Impact of race/ethnicity on SGLT-2 inhibitors/GLP-1 agonist prescriptions in type 2 diabetes
- Early time-restricted eating in obese adults
- Open-source automated insulin delivery in type 1 diabetes
- Closed-loop therapy and C-peptide secretion preservation in type 1 diabetes
- Glycemia reduction in type 2 diabetes: glycaemic, microvascular and CV outcomes
- Teleclinics for managing diabetes in pregnancy
- Illness perceptions and self-care behaviours in NZers with type 2 diabetes
- Patient-led rapid basal insulin titration in gestational diabetes
- Dapagliflozin for preventing kidney disease in type 2 diabetes
- MetSSS and metabolic health status in multi-ethnic NZ cohorts
Please login below to download this issue (PDF)